secwatch.observer — SEC 8-K summary
======================================

Issuer:     SRx Health Solutions, Inc. (SRXH)
CIK:        0001471727
Form:       8-K
Filed at:   2023-11-14T23:59:59+00:00
Accession:  0001493152-23-040675
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Better Choice Q3 revenue rises 11% YoY to $13.1M; net loss improves 75%
-----------------------------------------------------------------------

- Revenue of $13.1M, up 11% YoY and 24% from Q2 2023; 75% from Halo Holistic product line.
- Operating loss improved 59% YoY to $(2.6)M; operating margin improved 3,403 bps to (20%).
- Net loss improved 75% YoY to $(1.6)M; EPS improved 77% to ($0.05) per share.
- Adjusted EBITDA improved 95% YoY to $(0.1)M; Adjusted EBITDA margin improved 2,311 bps to (1%).
- Newly appointed CEO Kent Cunningham highlighted organic digital growth and cost improvements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1471727/000149315223040675/0001493152-23-040675-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1471727/000149315223040675/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-040675

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer